# SCRI Tissue Testing Registry

> **NCT00965861** · — · TERMINATED · sponsor: **SCRI Development Innovations, LLC** · enrollment: 20 (actual)

## Conditions studied

- Melanoma
- Myelodysplastic Syndrome
- Multiple Myeloma
- Lymphoma

## Interventions

- **OTHER:** Tissue Registry Study

## Key facts

- **NCT ID:** NCT00965861
- **Lead sponsor:** SCRI Development Innovations, LLC
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-05
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Replaced by a study with a similar design.
- **Last updated:** 2013-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965861, "SCRI Tissue Testing Registry". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00965861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*